The health‑tech startup is using AI to analyze biometric data from a smart ring to diagnose sleep apnea and offer treatment options.
Happy Health, a health‑tech startup, announced a $75 million Series B round to accelerate its AI‑driven sleep‑apnea ring, a wearable that captures biometric signals and delivers diagnostic insights directly to users.
Funding Round and Investors
The financing was led by Sequoia Capital with participation from Benchmark, 500 Global, and existing backers including AngelList. The capital will fund product scaling, regulatory clearance, and expanded clinical partnerships.
How the Ring Works
Worn on the finger, the ring continuously records oxygen saturation, heart rate variability, and motion patterns throughout the night. Proprietary AI models analyze these streams to detect apnea events with accuracy comparable to home sleep‑study devices.
When the algorithm identifies abnormal breathing patterns, the app presents a risk score, personalized sleep‑health recommendations, and options to connect with sleep specialists for further evaluation.
Clinical Validation and Partnerships
Happy Health has partnered with three major sleep clinics to validate its technology against polysomnography, the gold‑standard diagnostic test. Early results show a sensitivity of 88 % and specificity of 85 % for moderate‑to‑severe apnea.
- Integration with electronic health‑record systems for seamless data sharing
- Pilot programs at university hospitals in Boston and San Francisco
- Collaboration with insurance providers to explore coverage options
Market Outlook
Sleep apnea affects an estimated 22 million adults in the United States alone, yet many remain undiagnosed. By offering a low‑cost, at‑home diagnostic tool, Happy Health aims to capture a sizable share of the growing digital‑health wearables market.
Our mission is to make sleep‑apnea screening as easy as checking your heart rate.
The company plans to launch the ring commercially in early 2027, targeting both consumer and clinical channels.